Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations

Charles S Berenson1, Ragina L Kruzel1, Ellana Eberhardt2

  • 1Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine, Buffalo, New York, USA.

Thorax
|April 2, 2014
PubMed
Abstract

Insights

In Chronic Obstructive Pulmonary Disease (COPD), impaired alveolar macrophage (AM) responses to pathogens, particularly via Toll-like receptor (TLR) pathways, are linked to increased exacerbations. This study reveals dysfunctional innate immunity in COPD exacerbation-prone individuals.

Area of Science:

  • Immunology
  • Pulmonology
  • Infectious Disease

Background:

  • Alveolar macrophages (AMs) in Chronic Obstructive Pulmonary Disease (COPD) exhibit impaired responses to Toll-like receptor 2 (TLR2) and TLR4 ligands from non-typeable Haemophilus influenzae (NTHI).
  • The role of innate immune dysfunction in COPD exacerbations remains largely unexplored.
  • This study hypothesizes that impaired innate AM responses in COPD extend to other pathogens and correlate with exacerbation frequency and disease severity.

Purpose of the Study:

  • To investigate the innate immune response of AMs from COPD patients to various respiratory pathogens and TLR ligands.
  • To determine if impaired AM responses are associated with a propensity for COPD exacerbations.
  • To explore the link between AM dysfunction, TLR signaling, and COPD exacerbation risk.

Main Methods:

  • Bronchoalveolar lavage (BAL) was performed on 88 stable-to-moderate COPD volunteers.
  • AMs were stimulated with respiratory pathogens (NTHI, Moraxella catarrhalis, Streptococcus pneumoniae) and TLR ligands (lipopolysaccharide, Pam3Cys).
  • Cytokine (IL-8, TNF-α) production, NF-κB activation, and AM TLR expression were measured. Participants were prospectively monitored for exacerbations over one year.

Main Results:

  • Exacerbation-prone individuals (29/88) showed significantly more refractory AMs to cytokine induction by NTHI, MC, and SP compared to exacerbation-free individuals (59/88).
  • Impaired NF-κB nuclear translocation and diminished TLR2/TLR4 upregulation on AMs were observed in exacerbation-prone COPD donors.
  • Refractory responses to TLR2 and TLR4 ligands were more pronounced in AMs from exacerbation-prone COPD patients.

Conclusions:

  • The findings support a paradigm of impaired innate immune responses in COPD AMs to common respiratory pathogens.
  • Dysfunctional Toll-like receptor (TLR) signaling in AMs contributes to the propensity for exacerbations in COPD.
  • Targeting innate immune dysfunction in AMs may offer therapeutic strategies for reducing COPD exacerbations.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K